Amgen's sales slid in 2019. So why did CEO Bradway score a $1M-plus raise?

8th April 2020 Uncategorised 0

Amgen has been battling a storm of generics and biosimilars—and last year posted a sales decline. But it still awarded its chief executive a total pay increase of more than $1 million. Why? Advances elsewhere, the company’s proxy says.

More: Amgen's sales slid in 2019. So why did CEO Bradway score a M-plus raise?
Source: fierce